Copyright Reports & Markets. All rights reserved.

Global Antibiotic Resistance Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Antibiotic Resistance
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antibiotic Resistance Consumption Value by Type: 2019 Versus 2023 Versus 2030
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antibiotic Resistance Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Oxazolidinones
    • 1.4.3 Lipoglycopeptides
    • 1.4.4 Tetracyclines
    • 1.4.5 Cephalosporins
    • 1.4.6 Combination therapies
    • 1.4.7 Other
  • 1.5 Global Antibiotic Resistance Market Size & Forecast
    • 1.5.1 Global Antibiotic Resistance Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Antibiotic Resistance Sales Quantity (2019-2030)
    • 1.5.3 Global Antibiotic Resistance Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Allergan
    • 2.1.1 Allergan Details
    • 2.1.2 Allergan Major Business
    • 2.1.3 Allergan Antibiotic Resistance Product and Services
    • 2.1.4 Allergan Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Allergan Recent Developments/Updates
  • 2.2 AmpliPhi Biosciences
    • 2.2.1 AmpliPhi Biosciences Details
    • 2.2.2 AmpliPhi Biosciences Major Business
    • 2.2.3 AmpliPhi Biosciences Antibiotic Resistance Product and Services
    • 2.2.4 AmpliPhi Biosciences Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 AmpliPhi Biosciences Recent Developments/Updates
  • 2.3 BioVersys GmbH
    • 2.3.1 BioVersys GmbH Details
    • 2.3.2 BioVersys GmbH Major Business
    • 2.3.3 BioVersys GmbH Antibiotic Resistance Product and Services
    • 2.3.4 BioVersys GmbH Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 BioVersys GmbH Recent Developments/Updates
  • 2.4 Macrolide Pharmaceuticals
    • 2.4.1 Macrolide Pharmaceuticals Details
    • 2.4.2 Macrolide Pharmaceuticals Major Business
    • 2.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Product and Services
    • 2.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Macrolide Pharmaceuticals Recent Developments/Updates
  • 2.5 Melinta Therapeutics
    • 2.5.1 Melinta Therapeutics Details
    • 2.5.2 Melinta Therapeutics Major Business
    • 2.5.3 Melinta Therapeutics Antibiotic Resistance Product and Services
    • 2.5.4 Melinta Therapeutics Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Melinta Therapeutics Recent Developments/Updates
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Antibiotic Resistance Product and Services
    • 2.6.4 Merck Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck Recent Developments/Updates
  • 2.7 Nabriva Therapeutics
    • 2.7.1 Nabriva Therapeutics Details
    • 2.7.2 Nabriva Therapeutics Major Business
    • 2.7.3 Nabriva Therapeutics Antibiotic Resistance Product and Services
    • 2.7.4 Nabriva Therapeutics Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Nabriva Therapeutics Recent Developments/Updates
  • 2.8 Nemesis Bioscience
    • 2.8.1 Nemesis Bioscience Details
    • 2.8.2 Nemesis Bioscience Major Business
    • 2.8.3 Nemesis Bioscience Antibiotic Resistance Product and Services
    • 2.8.4 Nemesis Bioscience Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Nemesis Bioscience Recent Developments/Updates
  • 2.9 Phage Technologies S.A
    • 2.9.1 Phage Technologies S.A Details
    • 2.9.2 Phage Technologies S.A Major Business
    • 2.9.3 Phage Technologies S.A Antibiotic Resistance Product and Services
    • 2.9.4 Phage Technologies S.A Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Phage Technologies S.A Recent Developments/Updates
  • 2.10 Tetraphase Pharmaceuticals
    • 2.10.1 Tetraphase Pharmaceuticals Details
    • 2.10.2 Tetraphase Pharmaceuticals Major Business
    • 2.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Product and Services
    • 2.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Tetraphase Pharmaceuticals Recent Developments/Updates
  • 2.11 The Medicines Company
    • 2.11.1 The Medicines Company Details
    • 2.11.2 The Medicines Company Major Business
    • 2.11.3 The Medicines Company Antibiotic Resistance Product and Services
    • 2.11.4 The Medicines Company Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 The Medicines Company Recent Developments/Updates
  • 2.12 TPfizer
    • 2.12.1 TPfizer Details
    • 2.12.2 TPfizer Major Business
    • 2.12.3 TPfizer Antibiotic Resistance Product and Services
    • 2.12.4 TPfizer Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 TPfizer Recent Developments/Updates
  • 2.13 Westway Health
    • 2.13.1 Westway Health Details
    • 2.13.2 Westway Health Major Business
    • 2.13.3 Westway Health Antibiotic Resistance Product and Services
    • 2.13.4 Westway Health Antibiotic Resistance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Westway Health Recent Developments/Updates

3 Competitive Environment: Antibiotic Resistance by Manufacturer

  • 3.1 Global Antibiotic Resistance Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Antibiotic Resistance Revenue by Manufacturer (2019-2024)
  • 3.3 Global Antibiotic Resistance Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Antibiotic Resistance by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Antibiotic Resistance Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Antibiotic Resistance Manufacturer Market Share in 2023
  • 3.5 Antibiotic Resistance Market: Overall Company Footprint Analysis
    • 3.5.1 Antibiotic Resistance Market: Region Footprint
    • 3.5.2 Antibiotic Resistance Market: Company Product Type Footprint
    • 3.5.3 Antibiotic Resistance Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antibiotic Resistance Market Size by Region
    • 4.1.1 Global Antibiotic Resistance Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Antibiotic Resistance Consumption Value by Region (2019-2030)
    • 4.1.3 Global Antibiotic Resistance Average Price by Region (2019-2030)
  • 4.2 North America Antibiotic Resistance Consumption Value (2019-2030)
  • 4.3 Europe Antibiotic Resistance Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Antibiotic Resistance Consumption Value (2019-2030)
  • 4.5 South America Antibiotic Resistance Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Antibiotic Resistance Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Antibiotic Resistance Sales Quantity by Type (2019-2030)
  • 5.2 Global Antibiotic Resistance Consumption Value by Type (2019-2030)
  • 5.3 Global Antibiotic Resistance Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Antibiotic Resistance Sales Quantity by Application (2019-2030)
  • 6.2 Global Antibiotic Resistance Consumption Value by Application (2019-2030)
  • 6.3 Global Antibiotic Resistance Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Antibiotic Resistance Sales Quantity by Type (2019-2030)
  • 7.2 North America Antibiotic Resistance Sales Quantity by Application (2019-2030)
  • 7.3 North America Antibiotic Resistance Market Size by Country
    • 7.3.1 North America Antibiotic Resistance Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Antibiotic Resistance Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Antibiotic Resistance Sales Quantity by Type (2019-2030)
  • 8.2 Europe Antibiotic Resistance Sales Quantity by Application (2019-2030)
  • 8.3 Europe Antibiotic Resistance Market Size by Country
    • 8.3.1 Europe Antibiotic Resistance Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Antibiotic Resistance Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antibiotic Resistance Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Antibiotic Resistance Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Antibiotic Resistance Market Size by Region
    • 9.3.1 Asia-Pacific Antibiotic Resistance Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Antibiotic Resistance Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Antibiotic Resistance Sales Quantity by Type (2019-2030)
  • 10.2 South America Antibiotic Resistance Sales Quantity by Application (2019-2030)
  • 10.3 South America Antibiotic Resistance Market Size by Country
    • 10.3.1 South America Antibiotic Resistance Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Antibiotic Resistance Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antibiotic Resistance Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Antibiotic Resistance Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Antibiotic Resistance Market Size by Country
    • 11.3.1 Middle East & Africa Antibiotic Resistance Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Antibiotic Resistance Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Antibiotic Resistance Market Drivers
  • 12.2 Antibiotic Resistance Market Restraints
  • 12.3 Antibiotic Resistance Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antibiotic Resistance and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antibiotic Resistance
  • 13.3 Antibiotic Resistance Production Process
  • 13.4 Antibiotic Resistance Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antibiotic Resistance Typical Distributors
  • 14.3 Antibiotic Resistance Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Antibiotic Resistance market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Antibiotic Resistance industry chain, the market status of Oxazolidinones (, ), Lipoglycopeptides (, ), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antibiotic Resistance.
    Regionally, the report analyzes the Antibiotic Resistance markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antibiotic Resistance market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Antibiotic Resistance market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antibiotic Resistance industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., , ).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antibiotic Resistance market.
    Regional Analysis: The report involves examining the Antibiotic Resistance market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antibiotic Resistance market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Antibiotic Resistance:
    Company Analysis: Report covers individual Antibiotic Resistance manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antibiotic Resistance This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oxazolidinones, Lipoglycopeptides).
    Technology Analysis: Report covers specific technologies relevant to Antibiotic Resistance. It assesses the current state, advancements, and potential future developments in Antibiotic Resistance areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antibiotic Resistance market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Antibiotic Resistance market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    By Disease
    By Pathogen
    Market segment by Application
    Oxazolidinones
    Lipoglycopeptides
    Tetracyclines
    Cephalosporins
    Combination therapies
    Other
    Major players covered
    Allergan
    AmpliPhi Biosciences
    BioVersys GmbH
    Macrolide Pharmaceuticals
    Melinta Therapeutics
    Merck
    Nabriva Therapeutics
    Nemesis Bioscience
    Phage Technologies S.A
    Tetraphase Pharmaceuticals
    The Medicines Company
    TPfizer
    Westway Health
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Antibiotic Resistance product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Antibiotic Resistance, with price, sales, revenue and global market share of Antibiotic Resistance from 2019 to 2024.
    Chapter 3, the Antibiotic Resistance competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Antibiotic Resistance breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antibiotic Resistance market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Antibiotic Resistance.
    Chapter 14 and 15, to describe Antibiotic Resistance sales channel, distributors, customers, research findings and conclusion.

    Buy now